new-drug-application Archives

Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benefit in Phase 2b/3 Clinical Trial

LOS ANGELES, CA -- (Marketwired) -- 03/28/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR)Data Supports Further Clinical…